Sokal Score (CML Prognosis)

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۰۰ • واحد: years

حداقل ۰ — حداکثر ۴۰ • واحد: cm

حداقل ۲۰ — حداکثر ۳۰۰۰ • واحد: x10^9/L

حداقل ۰ — حداکثر ۳۰ • واحد: %

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
sokal
—score
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low risk0–0.8
  • Intermediate risk0.8–1.2
  • High risk1.2–100
Direct Clinical Answer

The Sokal Score (CML Prognosis) calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include age. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

CML prognostic score at diagnosis: <0.8 low, 0.8-1.2 intermediate, >1.2 high risk.

Clinical Indication

The Sokal Score (CML Prognosis) is indicated for bedside clinical practice to support CML prognostic score at diagnosis: <0.8 low, 0.8-1.2 intermediate, >1.2 high risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.

Formula & Variables:

exp(0.0116x(age-43.4) + 0.0345x(spleen-7.51) + 0.188x((plt/700)^2-0.563) + 0.0887x(blasts-2.1))

Input Parameters

NameTypeRequiredDescription
ageintegerYesAge(years)
spleen_cmfloatYesSpleen palpable below costal margin(cm)
plateletsfloatYesPlatelets(x10^9/L)
blastsfloatYesPeripheral blasts(%)

Score Interpretation & Guidance

RangeStageDescription
0–0.8Low riskLow risk
0.8–1.2Intermediate riskIntermediate risk
1.2–100High riskHigh risk

Evidence-Based References (EBM)

  • Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in good-risk chronic granulocytic leukemia. Blood. 1984;63(4):789-799.

Related calculators